In Australia, researchers have begun clinical trials of a new type of COVID-19 vaccine, the nasal spray. The vaccine is believed to be more effective than AstraZeneca and Pfizer.
Vaccinations are accelerating in Australia. It is planned to introduce a nasal spray that will “attack the virus” when it enters the body.
Nucleus Network head Dr. Paul Griffin said that while other drugs mainly protect against the development of serious symptoms of COVID-19, this one aims to reduce the risk of infection.
- Does This Mean We Stopped Being Animal and Started Being Human Due to ‘Copy Paste’ Errors?
- The One Lifestyle Choice That Could Reduce Your Heart Disease Risk By More Than 22%
- Aging: This Is What Happens Inside Your Body Right After Exercise
- Immune-Boosting Drink that Mimics Fasting to Reduce Fat – Scientists ‘Were Surprised’ By New Findings
- Gun Violence in America: What They Don’t Talk About at the Debate
“The main benefit is, when we give the vaccine via the same route that the pathogen or the virus gets in through, then hopefully the response will be more adept at actually stopping the virus getting in,” he said.
So, we will get a response that is particularly active at that site, which will hopefully mean that people are much less likely to get infected, which is something that we really want to see with vaccines for this virus
The nasal spray will be available in 1 or 2 years, the researchers said.
The government plans to vaccinate every Australian seeking the vaccine by the end of 2021. Australia has already reported about 30,000 cases of COVID. At the same time, more than 9 hundred people died.
Photo by Brook Mitchell/Getty Images